Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
15.34 EUR | -0.90% | -2.54% | -42.76% |
Apr. 09 | BASTIDE LE CONFORT MEDICAL : EPS upgrade (2023: 0.0%, 2024: +1.6%) | |
Apr. 09 | Bastide: new contract with the British NHS | CF |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Its low valuation, with P/E ratio at 5.84 and 5.15 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-42.76% | 122M | - | ||
-4.75% | 2.97B | B- | ||
0.00% | 1.76B | - | ||
+4.80% | 1.56B | C | ||
+42.56% | 597M | D+ | ||
-1.26% | 507M | - | ||
-37.30% | 356M | - | ||
-15.25% | 138M | - | ||
+3.85% | 68.96M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BLC Stock
- Ratings Bastide Le Confort Médical